Two Sigma Investments, LP Nevro Corp Call Options Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $559,383 - $836,901	6,900 Added 143.75%	11,700 $949,000
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $203,980 - $332,720	2,000 Added 71.43%	4,800 $559,000
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $55,267 - $73,736	-400 Reduced 12.5%	2,800 $485,000
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $35,780 - $51,940	400 Added 14.29%	3,200 $382,000
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $7,023 - $14,431	-100 Reduced 3.45%	2,800 $280,000
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $160,461 - $246,834	-2,100 Reduced 42.0%	2,900 $341,000
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $61,520 - $91,100	1,000 Added 25.0%	5,000 $430,000
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $176,880 - $301,880	4,000 New	4,000 $228,000
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $752,752 - $962,000	-10,400 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $722,383 - $921,127	10,400 New	10,400 $901,000

150

39.4M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $144M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.